Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High acceptability and satisfaction with NuvaRing use.

A Szarewski1

  • 1Department of Mathematics. Statistics & Epidemiology, Cancer Research UK, London, UK.

The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception
|March 28, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discussion.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2017
Same author

Comparing the performance of six human papillomavirus tests in a screening population.

British journal of cancer·2013
Same author

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18.

International journal of cancer·2011
Same author

HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial.

British journal of cancer·2011
Same author

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study.

British journal of cancer·2010
Same author

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

Lancet (London, England)·2009
Same journal

Dissociation of gonadal and adrenal androgens one year after etonogestrel implant insertion.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same journal

A titrated low-dose misoprostol protocol for second-trimester abortion (13-26 weeks) in women with one prior cesarean and preterm premature rupture of membranes: a clinical practice report.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same journal

Factors associated with unplanned pregnancy among pregnant female adolescents in the Southeast region of Brazil: a cross-sectional study.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same journal

Contraceptive effectiveness of a digital contraceptive with a wearable device vs an oral thermometer.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same journal

Fertile-window misclassification in period-tracking applications and associated pregnancy risk: a large observational analysis.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
Same journal

Measurement of pain during first trimester medical abortion: an exploratory qualitative study.

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception·2026
See all related articles

NuvaRing, a combined contraceptive vaginal ring, demonstrates high user satisfaction and acceptability. Most women would recommend this hormonal contraception method, reporting comfort and ease of use.

Area of Science:

  • Reproductive Health
  • Contraception
  • Gynecology

Background:

  • NuvaRing is a combined contraceptive vaginal ring releasing ethinylestradiol and etonogestrel.
  • It involves 3 weeks of use followed by a 1-week ring-free period.
  • User insertion and removal are designed for self-management.

Purpose of the Study:

  • To assess the acceptability and satisfaction of NuvaRing among users.
  • To evaluate user experiences with NuvaRing compared to previous contraceptive methods.

Main Methods:

  • Two large, multicenter, open-label, 1-year studies.
  • Data collected via questionnaires from 2393 women.
  • Analysis of 1950 (82%) women who completed cycle 3 questionnaires.

Related Experiment Videos

Main Results:

  • High user satisfaction (over 90%) and acceptability reported.
  • Most women (97%) would recommend NuvaRing.
  • Reported reductions in menstrual pain and period length.
  • Ease of insertion/removal noted; minimal partner objection to ring presence during intercourse.

Conclusions:

  • NuvaRing exhibits good user acceptability and high satisfaction levels.
  • High satisfaction predicts lower discontinuation rates.
  • NuvaRing is preferred by over 80% of users as a first-choice method.